Study to Evaluate Safety and Efficacy of Early Calcineurin Inhibitor Withdrawal in Primary Renal Allografts

NCT00374647 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

17

Enrollment

OTHER

Sponsor class

Conditions

Primary Renal Allograft

Interventions

DRUG: mycophenolate mofetil
DRUG: sirolimus

Sponsor

University of Cincinnati